Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMBI Brite Bites

This article was originally published in The Tan Sheet

Executive Summary

Firm launches nutrition bar, similar to Lite Bites, on the QVC network in the U.K. the week of Oct. 13, six to eight weeks ahead of schedule. The event follows the late September release of the dietary supplement bar Sweet Support on QVC in the U.S., also ahead of schedule. The Purchase, N.Y.-based firm additionally expects to debut its patented Chromax chromium picolinate line in the first half of 2000. "Revenues from the Lite Bites line of dietary supplement bars...exceeded our initial expectations and, as a result, we accelerated our bar product development programs," the company says. AMBI acquired Lite Bites through the purchase of Optimum Lifestyle in January (1"The Tan Sheet" Jan. 25, In Brief)

You may also be interested in...



AMBI NoYo Fat Fighting System Aims To Cut Yo-Yo Dieting

Nutrition 21's new line of NoYo dietary supplements, scheduled to launch in food, drug and mass markets by the end of November, carries the tagline, "No more yo-yo dieting!"

AMBI NoYo Fat Fighting System Aims To Cut Yo-Yo Dieting

Nutrition 21's new line of NoYo dietary supplements, scheduled to launch in food, drug and mass markets by the end of November, carries the tagline, "No more yo-yo dieting!"

AMBI NoYo Fat Fighting System Aims To Cut Yo-Yo Dieting

Nutrition 21's new line of NoYo dietary supplements, scheduled to launch in food, drug and mass markets by the end of November, carries the tagline, "No more yo-yo dieting!"

Related Content

Topics

UsernamePublicRestriction

Register

PS090426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel